Biotop-report 2012

13

BIONNALE – Networking at the industry’s largest 

convention in the German Capital Region 

The annual BIONNALE – the Berlin-Brandenburg biotechnology 

industry’s most important convention – is also regarded as an 

ideal platform for gathering information about existing funding 

potential for biotech companies in the region, as well as learning 

about the latest scientific and economic developments. On the 

BIONNALE Venture Market, the BIONNALE Contact Forum and 

at the evening get-together, progress was achieved for a large 

number of partnerships, projects and funding agreements. This 

year, the BIONNALE has celebrated its 10th anniversary with 

more than 500 guests. 

BioTOPics 44 | May 2012 

BioTOP-Report 

---

Contact us: 

Phone: +49 (0)30 / 2125-4747 

E-mail: [e-mail]

www.ibb.de/wachsen

Our tailored fi nancing are your key to success. 

Our consultants look forward to meeting you.

Getting your 

innovation going.

---

ORGANOBALANCE GmbH

In Harmony with Nature 

ORGANOBALANCE exploits the potential of 

probiotic bacteria and yeasts for new prod-

uct developments in food, feed, personal 

care, for the pharmaceutical industry and for 

the production of fine chemicals. From a 

large number of microorganisms, specific 

strains are selected to inactivate pathogenic 

microorganisms, add new activities, neutral-

ize malodorous/toxic substances or produce 

high titers of valuable compounds.

ORGANOBALANCE relies on a variety of nat-

ural resources, which are gathered in a com-

pany-owned collection of 8000+ microbial 

strains, mostly originating from foodstuffs. 

ORGANOBALANCE uses its OASSYS

®

 bioas-

says for highly efficient screenings. This plat-

form allows the quick identification of most 

suitable strains from the microbial collection 

for new applications.

ORGANOBALANCE has a broad expertise in 

the field of yeast metabolic engineering. 

This includes the design and development of 

new production strains for industrial bio-

technology applications. Specific production 

strains of Saccharomyces cerevisiae, which 

carry engineered biosynthesis pathways for 

the environmentally friendly production of 

carboxylic acids, terpenoids, steroids and 

other lipid compounds are developed.

ORGANOBALANCE works in exclusive col-

laboration with its partners and grants 

licenses for own product developments.

Address

ORGANOBALANCE GmbH

Gustav-Meyer-Allee 25

13355 Berlin · Germany

Contact

Dr. Christine Lang · CEO

Phone  [phone]

Fax 

[phone]

[e-mail]

www.organobalance.com

PAREXEL International

PAREXEL International is a leading global 

biopharmaceutical services organization, 

providing a broad range of knowledge-based 

contract research, medical communications 

and consulting services to the worldwide 

pharmaceutical, biotechnology and medical 

device industries. For 30 years, PAREXEL has 

been committed to providing solutions that 

expedite time-to-market and peak-market 

penetration, bringing significant expertise 

across the development and commercializa-

tion continuum, from drug development 

and regulatory consulting to clinical pharma-

cology, clinical trials management, medical 

education and reimbursement. Perceptive 

Informatics, Inc., a subsidiary of PAREXEL, 

provides advanced technology solutions, 

including medical imaging, to facilitate the 

clinical development process. Headquar-

tered near Boston, Massachusetts, PAREXEL 

operates in 71 locations throughout 52 

countries around the world, and has approx-

imately 11,300 employees. 

PAREXEL has a long-standing presence in 

Berlin, where over 1,500 employees are 

located. Clients can benefit from state-of-

the-art technologies and equipment provid-

ed through PAREXEL’s medical imaging lab 

and Early Phase Units, which provide a safe, 

high-quality environment for early phase 

development activities in a hospital setting. 

The PAREXEL Academy located in Berlin 

qualifies clinical research associates and 

clinical data managers, and offers a course 

for a Bachelor of Science degree in Clinical 

Research, validated by a British university. 

Address 

PAREXEL International GmbH

Klinikum Westend · Haus 18

Spandauer Damm 130

14050 Berlin · Germany

Contact

Dr. Ulf Schneider

Senior Vice President and  

Chief Administrative Officer  

PAREXEL International

Phone [phone]

Fax 

[phone]

[e-mail]

www.parexel.com

15

BioTOPics 44 | May 2012 

BioTOP-Report

---

ifp Institut für Produktqualität GmbH

Founded in 2004, ifp Institut für Produkt-

qualität GmbH is an independent compe-

tence center for the analysis of food, feed, 

water and pharmaceuticals, offering a com-

plete range of services. In addition, ifp devel-

ops and produces innovative products which 

are commercialized globally through a net-

work of selected distribution partners. In 

2012, ifp established a second laboratory 

center specialised in nutritional value and 

pesticide testing. The company currently 

employs 100 staff.

Food Analytics

The combination of expert staff, state-of-the-

art laboratory equipment and products spe-

cifically developed by ifp guarantees high-

quality analyses and competent service. 

The portfolio includes:

 

k

Allergens: qualitative and quantitative 

allergen analytics; allergen management 

consulting

 

k

Vitamins: determination of all water- and 

fat-soluble vitamins

 

k

Microbiology: microbiological and 

molecular biological detection of micro-

organisms in food and drinking water. 

Additionally, ifp offers hygiene manage-

ment consulting.

 

k

GMO: screening, identification and 

quantification of genetically modified 

organisms

 

k

Contaminants: analysis of mycotoxins, 

heavy metals, solvents etc.

 

k

Nutritional value: analysis of the basic 

food components, e. g. water, fat, pro-

tein, carbohydrates etc.

 

k

Residues: state-of-the-art analyses cov-

ering a broad spectrum of pesticides

Ifp also offers extensive auditing, quality 

assurance, and control services covering the 

entire production process. The ifp Quality 

Seal is awarded to products that undergo 

and pass this examination.

Pharma Analytics

Ifp meets the highest demands not only in 

food analytics but also in the field of phar-

maceuticals. The company has been GMP 

certified as per Section 14 (4) No. 3 of the 

German Drug Law, making it an official test-

ing laboratory for subcontracted drug analy-

ses in compliance with the Good Manufac-

turing Practice (GMP) guidelines. This autho-

rizes ifp to carry out microbiological tests 

relevant for the release of pharmaceutical 

products. The services include testing for 

microbial purity of non-sterile medical prod-

ucts, testing for sufficient antimicrobial pres-

ervation and bacteria endotoxins, identifica-

tion of microorganisms and analyses of 

water and monitoring samples.

Innovative Products

Several innovative product lines developed 

and produced by ifp are successfully distrib-

uted worldwide through renowned coopera-

tion partners. The microtiter plate-based 

VitaFast

®

 vitamin kits are distributed by 

R-Biopharm. In 2010, QIAGEN acquired the 

sales rights for ifp’s real-time PCR kits for 

the detection of pathogens, GMO, and other 

parameters which are now available under 

the trademark mericon

TM

. The AgraStrip

®

 

product line includes immunological lateral 

flow tests for the rapid screening of aller-

gens and is exclusively distributed globally 

by Romer Labs. 

In March 2011, ifp officially launched its 

fourth product line within five years, 

EnzymeFast

®

, for which ifp has been award-

ed the InterLabTec Award for Innovative 

Solutions for Analysis in Labs and Processing. 

More products are currently in the pipeline. 

Additionally, ifp is involved in several 

research projects.

Address

ifp Institut für Produktqualität GmbH

Teltowkanalstraße 2

12247 Berlin · Germany

Contact

Dr. Wolfgang Weber

General Manager

Phone [phone]

Fax 

[phone]

www.produktqualitaet.com

[e-mail]

16

BioTOPics 44 | May 2012 

BioTOP-Report

---